These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29401156)

  • 21. Clusterin and complement activation in exfoliation glaucoma.
    Doudevski I; Rostagno A; Cowman M; Liebmann J; Ritch R; Ghiso J
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2491-9. PubMed ID: 24550356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exfoliation syndrome: a disease with an environmental component.
    Dewundara S; Pasquale LR
    Curr Opin Ophthalmol; 2015 Mar; 26(2):78-81. PubMed ID: 25594763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of endothelin-1 concentration in aqueous humor with intraocular pressure in primary open angle and pseudoexfoliation glaucoma.
    Choritz L; Machert M; Thieme H
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7336-42. PubMed ID: 23036995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
    Schlötzer-Schrehardt U
    Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease-related quantitation of TGF-beta3 in human aqueous humor.
    Yoneda K; Nakano M; Mori K; Kinoshita S; Tashiro K
    Growth Factors; 2007 Jun; 25(3):160-7. PubMed ID: 18049952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Animal Models of Exfoliation Syndrome.
    Anderson MG; Meyer KJ; Hedberg-Buenz A; Fingert JH
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S78-S82. PubMed ID: 29419647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.
    Bernstein AM; Ritch R; Wolosin JM
    J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S44-S53. PubMed ID: 29547474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior.
    Li G; Schmitt H; Johnson WM; Lee C; Navarro I; Cui J; Fleming T; Gomez-Caraballo M; Elliott MH; Sherwood JM; Hauser MA; Farsiu S; Ethier CR; Stamer WD
    FASEB J; 2020 Aug; 34(8):10762-10777. PubMed ID: 32623782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of exfoliative glaucoma.
    Ritch R
    Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
    Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aqueous humor oxygen measurements.
    Nguyen A; Shui YB; Zhang Q; Beebe DC; Siegfried CJ
    J Glaucoma; 2013; 22(8):e23-4. PubMed ID: 23965524
    [No Abstract]   [Full Text] [Related]  

  • 32. The trabecular meshwork in normal eyes and in exfoliation glaucoma.
    Rasmussen CA; Kaufman PL
    J Glaucoma; 2014; 23(8 Suppl 1):S15-9. PubMed ID: 25275898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Associations of Exfoliation Syndrome.
    Ritch R
    Asia Pac J Ophthalmol (Phila); 2016; 5(1):45-50. PubMed ID: 26886119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population.
    Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
    Mol Vis; 2013; 19():1006-16. PubMed ID: 23687437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connective tissue growth factor is increased in pseudoexfoliation glaucoma.
    Browne JG; Ho SL; Kane R; Oliver N; Clark AF; O'Brien CJ; Crean JK
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3660-6. PubMed ID: 21330667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Biology of Exfoliation Syndrome.
    Schlötzer-Schrehardt U
    J Glaucoma; 2018 Jul; 27 Suppl 1():S32-S37. PubMed ID: 29419649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.
    Zenkel M; Lewczuk P; Jünemann A; Kruse FE; Naumann GO; Schlötzer-Schrehardt U
    Am J Pathol; 2010 Jun; 176(6):2868-79. PubMed ID: 20395431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular and systemic manifestations of exfoliation syndrome.
    Ritch R
    J Glaucoma; 2014; 23(8 Suppl 1):S1-8. PubMed ID: 25275896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oxidative stress and pseudoexfoliation glaucoma].
    Schlötzer-Schrehardt U
    Klin Monbl Augenheilkd; 2010 Feb; 227(2):108-13. PubMed ID: 20155654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship Between Choroidal Expansion and Intraocular Pressure Rise During the Water Drinking Test in Healthy Subjects and Patients With Exfoliation Syndrome.
    Kocabeyoglu S; Uzun S; Kadayifcilar S; Mocan MC; Irkec M
    J Glaucoma; 2016 Apr; 25(4):e324-8. PubMed ID: 26035419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.